THC THERAPEUTICS, INC.: 10-Q filed 2019-12-23
What THC THERAPEUTICS, INC. reported in its quarterly report filed 2019-12-23 (fiscal Q1 2020): 26 published measures, 56 facts as tagged in accession 0001477932-19-007263.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-12-23
- Fiscal period
- fiscal Q1 2020
- Accession
- 0001477932-19-007263 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All THC THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 418,145 | USD | |
| At 2019-07-31 | 520,022 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,300,733 | USD | |
| At 2019-07-31 | 1,269,428 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | -882,588 | USD | |
| At 2019-07-31 | -749,406 | USD | |
| At 2018-10-31 | 1,849,641 | USD | |
| At 2018-07-31 | 1,938,090 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 53,994 | USD | |
| At 2019-07-31 | 317,551 | USD | |
| At 2018-07-31 | 2,969 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -145,473 | USD | 92 |
| 2017-01-23 to 2019-10-31 | -32,846,609 | USD | 1012 |
| 2018-08-01 to 2018-10-31 | -438,856 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -131,609 | USD | 92 |
| 2018-08-01 to 2018-10-31 | -13,049 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 36,174 | USD | 92 |
| 2018-08-01 to 2018-10-31 | 11,275 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -168,122 | USD | 92 |
| 2018-08-01 to 2018-10-31 | -1,195 | USD | 92 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | -32,846,609 | USD | |
| At 2019-07-31 | -32,701,136 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 14,748,054 | shares | 92 |
| 2018-08-01 to 2018-10-31 | 13,003,589 | shares | 92 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -0.01 | USD/shares | 92 |
| 2018-08-01 to 2018-10-31 | -0.03 | USD/shares | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 31,811 | USD | |
| At 2019-07-31 | 37,143 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 2,259 | USD | 92 |
| 2018-08-01 to 2018-10-31 | 349,800 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -172,257 | USD | 92 |
| 2018-08-01 to 2018-10-31 | -407,736 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 194,244 | USD | |
| At 2019-07-31 | 457,801 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | -112,223 | USD | 92 |
| 2018-08-01 to 2018-10-31 | -5,773 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,300,733 | USD | |
| At 2019-07-31 | 1,269,428 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 23,968 | USD | |
| At 2019-07-31 | 28,287 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 172,257 | USD | 92 |
| 2018-08-01 to 2018-10-31 | 407,736 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 14,817,839 | shares | |
| At 2019-07-31 | 14,434,098 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 38,789,528 | USD | |
| At 2019-07-31 | 38,421,610 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 55,821 | USD | |
| At 2019-07-31 | 50,489 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 23,968 | USD | |
| At 2019-07-31 | 25,078 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 63,703 | USD | 92 |
| 2018-08-01 to 2018-10-31 | 17,821 | USD | 92 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 5,332 | USD | 92 |
| 2018-08-01 to 2018-10-31 | 5,287 | USD | 92 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 249,005 | USD | 92 |
| 2018-08-01 to 2018-10-31 | -41,498 | USD | 92 |
Inspect the source
- Entity
- THC THERAPEUTICS, INC. / CIK 0001404935
- Captured
- 2026-09-21T17:18:57.388Z
- SEC response SHA-256
f4626d642848143dc14fec3fdbe81fdaf088917037c5da7ecb43246b70ad052b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001404935.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))